Intel and Nvidia Lead AI Surge: Insights for Tech Investors
Intel and Nvidia drive market activity as inflation moderates, boosting tech sectors. Key insights for investors in US and Canadian markets.
Moderna's mRNA Flu Vaccine Approval: A Game Changer for Investors
Moderna's FDA approval of the first mRNA flu vaccine could redefine its market potential and growth trajectory.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
Phillips 66 and Marathon Petroleum in Merger Talks: What a Refining Megadeal Could Mean for Traders
Phillips 66 and Marathon Petroleum held takeover discussions, signaling potential industry consolidation. Traders are wa…
Brookfield and La Caisse's Boralex Acquisition: A New Era for Canadian Renewable Energy
Brookfield and La Caisse's acquisition of Boralex signals a significant move in Canada's renewable energy landscape.
Bristol Myers Squibb's FDA Approval: Is the Market Overreacting?
Bristol Myers Squibb's recent FDA approval raises questions about investor sentiment and stock valuation.
BridgeBio Pharma Stock Gains 29%: Analyzing Wall Street's Confidence
BridgeBio Pharma's stock has surged 29% in three months, reflecting strong earnings and bullish analyst support.
Lantheus Holdings' Tauklarify Approval: A Game Changer for Alzheimer's Imaging
Lantheus Holdings receives FDA approval for Tauklarify, enhancing its position in the Alzheimer's diagnostics market.
Capricor Therapeutics' Stock Soars 77%: What It Means for Investors
Capricor Therapeutics shares surged 77% after FDA agreed to review DMD drug data, signaling a turnaround for the biotech…
Analyzing Treasury Yield Movements Amid Geopolitical Tensions
As Treasury yields rise, geopolitical tensions and manufacturing data shape market landscapes.
Capricor Therapeutics: A High-Stakes Bet on FDA Decision
Capricor Therapeutics' stock surged 67% after-hours amidst anticipation of an FDA decision on deramiocel.
Mobix Labs Ventures into Critical Minerals: Strategic Acquisition Explained
Mobix Labs' strategic acquisition marks a pivotal shift into critical minerals, reshaping its market landscape.